Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.


The Atlantic
Accessed 29 Feb 2020
Democracies Are Better at Fighting Outbreaks
China’s harsh response to the coronavirus has influential admirers, but Western nations recognize that public health fundamentally depends on public trust.
February 24, 2020
Ariana A. Berengaut
Penn Biden Center’s director of programs, partnerships, and strategic planning

You’re Likely to Get the Coronavirus
Most cases are not life-threatening, which is also what makes the virus a historic challenge to contain.
James Hamblin
February 24, 2020


Accessed 29 Feb 2020
Coronavirus: Where are we with a vaccine?
By James Gallagher Health and science correspondent
27 February 2020


The Economist
Accessed 29 Feb 2020
[No new, unique, relevant content]


Financial Times
Accessed 29 Feb 2020
Lunch with the FT
Ebola co-discoverer Peter Piot on how to respond to the coronavirus
February 28 2020


Feb 28, 2020
Bill Gates: Governments Should Invest Billions To Battle ‘Once-In-A-Century’ Pathogen
“That’s the scale of investment required to solve the problem.”
By Lisette Voytko Forbes Staff


Foreign Affairs
Accessed 29 Feb 2020
[No new, unique, relevant content]


Foreign Policy
Accessed 29 Feb 2020
How Hackers and Spies Could Sabotage the Coronavirus Fight
Intelligence services have a long history of manipulating information on health issues, and an epidemic is especially tempting for interference. Why aren’t we better prepared?
Argument | Bruce Schneier, Margaret Bourdeaux


The West Is About to Fail the Coronavirus Test
China made huge mistakes managing the outbreak. The rest of the world may not do any better.
Argument | Melissa Chan, Ethan Guillén


Virus Travel Bans Are Inevitable But Ineffective
Experts can’t stop restrictions, but they can mitigate them.
Argument | Mara Pillinger


The Guardian
Accessed 29 Feb 2020
[No new, unique, relevant content]


New Yorker
Accessed 29 Feb 2020
[No new, unique, relevant content]


New York Times
Accessed 29 Feb 2020
Who’s on the U.S. Coronavirus Task Force
Several of the nation’s top health officials are among those sitting on an advisory panel formed by President Trump.
29 Feb 2020

Sunday Review
We’ve Ignored the Warnings About Global Pandemics
Now, after many fire drills, the world may be facing a real fire.
By The Editorial Board

Japan’s Leader Announces $2.5B Package to Help Fight Virus
Japanese Prime Minister Shinzo Abe on Saturday announced a 270 billion yen ($2.5 billion) emergency economic package to help fight the coronavirus as he sought the public’s support for his government’s fight against the outbreak.
By The Associated Press


Washington Post
Accessed 29 Feb 2020
Azar Says U.S.-Funded Drug, Vaccine Must Be Accessible (Feb 29, 202012:30 p.m. NY)
Any drug or vaccine developed by companies with help from the government must be financially accessible for people, Health and Human Services Secretary Alex Azar told Congress Thursday.
“I have directed my teams that if we do any joint venture with a private enterprise that we’re cofunding the research and development program that we would ensure there’s access to the fruits of that, whether vaccine or therapeutics,” Azar said at a congressional hearing. The U.S. government is collaborating with pharmaceutical and biotechnology firms to develop vaccines and drugs for the coronavirus.
Azar’s comments are a shift from remarks Wednesday, when he said, “we would want to ensure that we work to make it affordable, but we can’t control that price, because we need the private sector to invest. Price controls won’t get us there.”…